Rimegepant in the Treatment of Migraine Headache: The Importance of Comparator Treatments: November 2019 Annals of Emergency Medicine Journal Club
- PMID: 31668246
- DOI: 10.1016/j.annemergmed.2019.09.014
Rimegepant in the Treatment of Migraine Headache: The Importance of Comparator Treatments: November 2019 Annals of Emergency Medicine Journal Club
Comment on
-
Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine.N Engl J Med. 2019 Jul 11;381(2):142-149. doi: 10.1056/NEJMoa1811090. N Engl J Med. 2019. PMID: 31291516 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
